Chimerism Pre-Engraftment Donor & Recipient Test in UAE | 1800 AED

Executive Summary & Core Metrics

Premier UAE Lab

This ISO 15189 accredited test utilizes PCR-STR Fragment Analysis to precisely quantify donor-recipient chimerism prior to hematopoietic stem cell transplantation. Achieving 99.9% diagnostic sensitivity, results are delivered within 10–12 days via a secure portal with telephonic post-test clinical guidance from our Consultant Medical Geneticist.

Accuracy Guarantee: 99.9% Diagnostic Sensitivity via ISO Accredited Processing.
Premium Logistics: VIP Mobile Phlebotomy & Temperature-Controlled Cold-Chain Home Collection (Available daily from 8 AM to 11 PM).
Clinical Guidance: Telephonic Post-Test Clinical Guidance for comprehensive result interpretation.
Insurance: Direct Billing Verification via WhatsApp +971 54 548 8731.

Test Overview & Methodology

The Chimerism Pre-Engraftment Donor & Recipient Test evaluates the genetic profiles of both donor and recipient before hematopoietic stem cell transplantation using PCR-based Short Tandem Repeat (STR) fragment analysis. By establishing baseline DNA fingerprints, clinicians can monitor engraftment kinetics, detect early mixed chimerism, and adjust immunosuppressive regimens with molecular precision. This baseline is critical for distinguishing donor-derived hematopoiesis from recipient residual cells post-transplant.

Feature	Our Test	Closest Alternative
Methodology	PCR-STR Fragment Analysis (ISO 15189 Certified Lab)	Standard PCR without STR resolution
Turnaround Time	10–12 Days	14–21 Days
Price	AED 1,800	AED 2,500+
Sample Required	2 mL EDTA whole blood (each donor & recipient); refrigerated transport	4 mL each; often non-refrigerated
Clinical Validation	99.9% sensitivity, ISO accredited, DHA/MOHAP standard nomenclature	Not specified

Physician Insight & Safety Protocols

“As a Consultant Medical Geneticist overseeing transplant molecular monitoring, I regard the pre-engraftment chimerism assay as an indispensable baseline for post-transplant surveillance. The STR fingerprint establishes a definitive genetic roadmap, enabling clinicians to detect mixed chimerism or graft rejection with high sensitivity. This test is a critical component of precision transplant medicine and must always be integrated with full clinical assessments.”

— Lina Osama Zaki Quteineh, Consultant Medical Genetics, DHA Registration ID: 9294403

Medication Advisory & Safety Precautions

⚕️ Medication Warning

Do not discontinue any prescribed immunosuppressive, anticoagulant, or other medication without your transplant physician’s direct approval. The chimerism test is a monitoring tool and does not replace clinical management decisions.

🛑 Safety Exclusion Criteria & ER Red Flags

Exclusions: Minors (< 18 years) require DHA-approved guardian consent in compliance with Federal Decree-Law No. 4 of 2016 on Medical Liability. Active systemic infection, severe coagulopathy, or inability to provide 2 mL whole blood warrants deferral of home collection.
Red Flags – Seek Emergency Care: Sudden onset of fever >38.5°C, uncontrolled bleeding from the puncture site, or severe pain after the blood draw.

Patient FAQ & Clinical Guidance

1. Why is a pre-transplant chimerism test necessary?

This test establishes the definitive donor and recipient genetic fingerprint before transplantation. Without baseline profiles, early signs of mixed chimerism or graft failure cannot be distinguished from pre-existing recipient hematopoiesis. The result guides timely clinical interventions and personalized immunosuppression protocols.

2. How is the blood sample collected and what preparation is needed?

No fasting or special preparation is required. A certified phlebotomist collects 2 mL of whole blood in EDTA tubes from both the donor and recipient. The sample is shipped refrigerated (never frozen) in an ISO-validated cold-chain kit. DNA Labs UAE offers VIP mobile phlebotomy at your home, office, or hospital between 8 AM and 11 PM daily.

3. When will I receive my results and how are they interpreted?

Results are typically available within 10–12 working days and include a detailed explanation of the donor-recipient allele pattern. You will receive a secure portal link and a telephonic consultation with our clinical team. Final interpretation must be performed by your hematologist or transplant physician, correlating the molecular findings with your clinical status.

UAE Regulatory & Data Privacy Adherence

DNA Labs UAE strictly adheres to the UAE legislative framework for health data and diagnostics. All chimerism testing is conducted under the operational license of the Dubai Health Authority (DHA) and complies with:

Federal Decree-Law No. 45 of 2021 on Personal Data Protection (PDPL) – governing the processing and confidentiality of personal health data.
Federal Law No. 2 of 2019 Concerning the Use of Information and Communication Technology in Health Fields – ensuring secure digital health records and telemedicine practices.
Federal Decree-Law No. 4 of 2016 on Medical Liability – safeguarding patient consent, clinical safety, and professional accountability.

Clinical & Logistical Metadata

Test Name	Chimerism Pre-Engraftment Donor & Recipient Test
Price (AED)	1,800
Turnaround Time	10–12 Business Days
Sample Type / Matrix	Peripheral Whole Blood (2 mL EDTA per donor & recipient)
Methodology Used	PCR-STR Fragment Analysis
ICD-10-CM Code	Z94.8
LOINC Code	97509-4
DHA Facility License & Laboratory Address	1143 \| Premises 105, Floor 1, Building 33, Dubai Healthcare City, Dubai, UAE